SEC Form 4 · accession 0001683168-16-000124
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yutaka Kobayashi
Director
Period of report
Sep 15, 2016
Accepted (ET)
Sep 15, 2016 · 2:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 15, 2016 | P | 11,800 | $6.44 | A | 81,800 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported shares were purchased with Japanese Yen in multiple transactions. The purchase price reported in Column 4 is a weighted average price at prices ranging from $6.39 to $6.47 inclusive, reflected in US Dollars, based on the applicable currency exchange rate in effect on the date of purchase, rounded to the nearest whole cent. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.